A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)
Status:
Recruiting
Trial end date:
2024-08-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics of efinopegdutide in
participants with hepatic impairment compared to healthy participants, and to examine the
safety and tolerability of efinopegdutide.